Proshares Short MSCI Emr MKTEUMETF

13F holders, Q3 2025 (September 30)
4holders −1
2new positions
3sold out
$20.90avg. 13F price*

At the end of Q3 2025, 4 institutions reported holding Proshares Short MSCI Emr MKT (EUM) in their 13F filings, down 1 from Q2 2025. 2 opened new positions and 3 sold out. The largest holders were Geneos Wealth Management Inc. ($6K), UBS Group AG ($2K) and Tower Research Capital LLC (TRC) ($84).

Company
Proshares Short MSCI Emr MKT
CUSIP
74349Y746
Latest filing quarter
Q2 2026

History

Number of 13F holders

02468 Q4 2024: 6Q4 2024Q1 2025: 7Q1 2025Q2 2025: 5Q2 2025Q3 2025: 4Q3 2025Q4 2025: 4Q4 2025Q1 2026: 8Q1 2026Q2 2026: 6Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions2$3K
Exits3$440K

All 13F filers, Q2 2025 → Q3 2025: 123 shares bought and 19,098 shares sold, net −18,975 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 4 holders

Geneos Wealth Management Inc. 0.00% No change 310 $6K
UBS Group AG 0.00% New 119 $2K
Tower Research Capital LLC (TRC) 0.00% New 4 $84
Farther Finance Advisors, LLC 0.00% No change 3 $63

"% of holder's portfolio" is EUM's weight in each manager's 13F, not the share of Proshares Short MSCI Emr MKT the manager owns.